Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

NCT00848354 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Phase 1: Etanercept
DRUG: Phase 1: Methotrexate
DRUG: Phase 2: Optional ETN, SSZ, HCQ, MTX
DRUG: Phase 1: Methotrexate
DRUG: Phase 1: Conventiaonal DMARD

Sponsor

Pfizer

Collaborators

[object Object]